154 related articles for article (PubMed ID: 38609583)
1. Combination of Doxorubicin and Antiangiogenic Agents in Drug-Eluting Beads: In Vitro Loading and Release Dynamics in View of a Novel Therapeutic Approach for Hepatocellular Carcinoma.
Krokidis M; Fakitsa D; Malagari K; Karampelas T; Fokas D; Tamvakopoulos C; Chatziioannou A
Cardiovasc Intervent Radiol; 2024 May; 47(5):661-669. PubMed ID: 38609583
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting beads loaded with antiangiogenic agents for chemoembolization: in vitro sunitinib loading and release and in vivo pharmacokinetics in an animal model.
Fuchs K; Bize PE; Dormond O; Denys A; Doelker E; Borchard G; Jordan O
J Vasc Interv Radiol; 2014 Mar; 25(3):379-87, 387.e1-2. PubMed ID: 24468044
[TBL] [Abstract][Full Text] [Related]
3. In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study.
Lahti S; Ludwig JM; Xing M; Sun L; Zeng D; Kim HS
PLoS One; 2017; 12(4):e0174539. PubMed ID: 28384190
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic drug delivery from hydrophilic resorbable embolization microspheres: an in vitro study with sunitinib and bevacizumab.
Bédouet L; Verret V; Louguet S; Servais E; Pascale F; Beilvert A; Baylatry MT; Labarre D; Moine L; Laurent A
Int J Pharm; 2015 Apr; 484(1-2):218-27. PubMed ID: 25701631
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
Bagi CM; Gebhard DF; Andresen CJ
Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
7. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
[No Abstract] [Full Text] [Related]
8. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
9. In vitro comparative study of multimodal imaging nano-assembled microspheres with two clinical drug-eluting beads loaded with doxorubicin.
He Y; Xu T; Ding T; Gong Y; Zeng H; Xi Z; Ye Y; Song Z; Pan T; Zhang Z; Ma Q; Li L; Zhang Y; Shao G
Drug Deliv; 2023 Dec; 30(1):2197177. PubMed ID: 37078789
[TBL] [Abstract][Full Text] [Related]
10. The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study.
Klass D; Owen D; Buczkowski A; Chung SW; Scudamore CH; Weiss AA; Yoshida EM; Ford JA; Ho S; Liu DM
Anticancer Res; 2014 Jul; 34(7):3597-606. PubMed ID: 24982375
[TBL] [Abstract][Full Text] [Related]
11. Sunitinib-eluting beads for chemoembolization: methods for in vitro evaluation of drug release.
Fuchs K; Bize PE; Denys A; Borchard G; Jordan O
Int J Pharm; 2015 Mar; 482(1-2):68-74. PubMed ID: 25448554
[TBL] [Abstract][Full Text] [Related]
12. Effect of bead size and doxorubicin loading on tumor cellular injury after transarterial embolization and chemoembolization in a rat model of hepatocellular carcinoma.
Cortes AC; Nishiofuku H; Polak U; Minhaj AA; Lopez MS; Kichikawa K; Qayyum A; Whitley EM; Avritscher R
Nanomedicine; 2022 Jan; 39():102465. PubMed ID: 34571240
[TBL] [Abstract][Full Text] [Related]
13. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia as a target for drug combination therapy of liver cancer.
Bowyer C; Lewis AL; Lloyd AW; Phillips GJ; Macfarlane WM
Anticancer Drugs; 2017 Aug; 28(7):771-780. PubMed ID: 28542038
[TBL] [Abstract][Full Text] [Related]
15. Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants.
Namur J; Citron SJ; Sellers MT; Dupuis MH; Wassef M; Manfait M; Laurent A
J Hepatol; 2011 Dec; 55(6):1332-8. PubMed ID: 21703190
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of sunitinib loaded bioresorbable microspheres for potential application in arterial chemoembolization.
Weng L; Akurati S; Donelson RB; Rostamzadeh P; Golzarian J
Colloids Surf B Biointerfaces; 2017 Nov; 159():705-711. PubMed ID: 28881297
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma.
van Malenstein H; Maleux G; Vandecaveye V; Heye S; Laleman W; van Pelt J; Vaninbroukx J; Nevens F; Verslype C
Onkologie; 2011; 34(7):368-76. PubMed ID: 21734423
[TBL] [Abstract][Full Text] [Related]
18. Composition-property relationships for radiopaque composite materials: pre-loaded drug-eluting beads for transarterial chemoembolization.
Kilcup N; Tonkopi E; Abraham RJ; Boyd D; Kehoe S
J Biomater Appl; 2015 Jul; 30(1):93-103. PubMed ID: 25690386
[TBL] [Abstract][Full Text] [Related]
19. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
Brown KT; Do RK; Gonen M; Covey AM; Getrajdman GI; Sofocleous CT; Jarnagin WR; D'Angelica MI; Allen PJ; Erinjeri JP; Brody LA; O'Neill GP; Johnson KN; Garcia AR; Beattie C; Zhao B; Solomon SB; Schwartz LH; DeMatteo R; Abou-Alfa GK
J Clin Oncol; 2016 Jun; 34(17):2046-53. PubMed ID: 26834067
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of drug-eluting bead-transcatheter arterial chemoembolization using 100-300 μm versus 300-500 μm CalliSpheres microspheres in patients with advanced-stage hepatocellular carcinoma.
Yang T; Qin W; Sun X; Wang Y; Wu J; Li Z; Ji F; Zhang L; Liu W
J Cancer Res Ther; 2020; 16(7):1582-1587. PubMed ID: 33565503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
